Multi-Omics Integrative and Functional Analysis of Glia Maturation Factor-γ: Associations with Malignant Phenotypes and Immune Microenvironment Features in Glioblastoma
Year: 2026
Type: article
Abstract: Glioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults. Therapeutic outcomes are severely limited by temozolomide (TMZ) chemoresistance and the immunosuppressive tumor microenvironment (TME). Glia maturation factor-γ (GMFG) is linked to cytoskeletal and myeloid remodeling in other cancers, yet its roles in glioma remain poorly explored. We integrated multi-omics analyses to dissect GMFG expression, clinical associations, epigenetic mechanisms, and immune association. CCK-8, Celigo scratch, Transwell, and Annexin V-APC apoptosis assays were performed to elucidate the biological function of GMFG in GBM. GMFG was prioritized based on overlapping hypoxia, isocitrate dehydrogenase (IDH)-wildtype and TMZ-resistance gene signatures. GMFG was upregulated and correlated with adverse clinical features. GMFG knockdown suppressed the cell viability, migration, and invasion of GBM cells and increased Annexin V-APC positivity. GMFG genetic alterations were rare, and CpG hypomethylation across multiple regulatory regions correlated with transcriptional activation; the hypomethylated group showed higher mRNA expression. GMFG K74 acetylation was elevated in GBM and correlated with protein abundance. At single-cell resolution, Chemo_TAM dominated the GMFG-high myeloid population; CellChat predicted prominent signaling pathways underlying tumor–Chemo_TAM crosstalk. GMFG expression positively correlated with immunosuppressive markers and several immune checkpoint molecules; OncoPredict identified candidate drugs with lower predicted IC50 in GMFG-high tumors. Integrated bioinformatic analyses suggest that GMFG is associated with the malignant phenotype and immune microenvironment in glioma, as well as epigenetic alterations—hypomethylation and K74 acetylation. In vitro, GMFG promoted the viability, migration, and invasion of GBM cells, and reduced Annexin V-APC positivity.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: glioblastoma, temozolomide resistance, tumor microenvironment, immune microenvironment, hypoxia, isocitrate dehydrogenase wild-type, CpG hypomethylation, myeloid cells, TAM receptors, immune checkpoint molecules, cell migration and invasion, apoptosis, drug repurposing, epigenetic regulation
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7234412328
